Access cutting-edge viral infections treatment through this clinical trial at a research site in Houston. Study-provided care at no cost to qualified participants.
Access viral infections specialists in Houston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related viral infections treatment provided free
This Phase I-II dose-finding trial to determine the optimal dose of intravenous (IV) injection dose of donor-derived cytotoxic T lymphocytes (CTLs) specific for CMV, EBV, BKV and Adenovirus. A maximum of 36 patients will be treated in up to 18 cohorts each of size 2, with the first cohort treated at the lowest dose level 1, all successive doses chosen by the EffTox method, and no untried dose level skipped when escalating. The scientific goal of the trial is to determine an optimal IV-CTL cell
Sponsor: Catherine Bollard
Check if you qualify for this viral infections clinical trial in Houston, TX
If you're searching for viral infections treatment options in Houston, TX, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Houston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced viral infections specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.